Skip to content
  • Home
  • Graham Ball (Professor)
Graham Ball

Graham Ball

Staff Group(s)
Bioscience

Role

Professor Ball supervises the bioinformatics team; undergraduate and postgraduate research projects. He also teaches on the modules Bioinformatics; Statistics; and Environmental Science.

Career overview

Professor Ball has a BSc (Honours) in Applied Biology (2:1).

He became a Doctor of Philosophy in July 1996 after studying at Trent Polytechnic (Nottingham Trent University). His thesis was on the Use of artificial Neural Networks to model plant and Ozone interactions. Focussing on computational modelling of the effects of climatic factors on the response of plants (physiological and biochemical) to Ozone pollution with a view to modification of the UN set critical levels for ozone pollution for difference environmental conditions. Sponsored by Department of the Environment and the United Nations Economic Commission for Europe.

He has worked as a Professor of Bioinformatics at Nottingham Trent University since 2010.

Research areas

Over 25 years experience in the development and application of Bionfomatic algorithms using Artificial Neural Networks (ANNs) and other machine learning techniques.  Particular application to environmental modelling, medical diagnostics and business risk analysis.  Development of knowledge management and e-learning solutions incorporating aspects of the above technologies.  Educated to PhD level and with post doctoral experience in the subject areas described above, I seek to apply this knowledge to develop simplified solutions to complex real world problems.  One of my current goals is to apply this knowledge to business solutions. Professor Ball has vast experience of supervising research students and opportunities to carry out postgraduate research towards an MPhil / PhD exist, further information may be obtained from the NTU Graduate School. Specialties Include:
Machine Learning
Precision Medicine
Deep Learning
Bioinformatics
Systems Biology
Molecular Driver Identification
Drug target Identification
Understanding molecular processes in drug re-purposing
In silico prototyping of diagnostics
Data mining of complex data sets. Current research interests have focused on the development and application of bioinformatic algorithms using Artificial Neural Networks (ANNs) to medical diagnostics and statistics including:

  • Cancer systems biology and bioinformatics
  • Identification of prognostic, diagnostic and predictive biomarkers for disease and therapy
  • Derivation and development of prognostic indices for cancer
  • Characterisation of tumours from immuno-histochemical markers in breast cancer
  • Molecular diagnostic modelling of cancer disease characteristics from mass spectrometry data of tissue and serum
  • Strain and species characterisation of bacterial pathogens from MS and sequence data
  • Modelling immune response in prostate cancer.

External activity

I am the Chief Scientific Officer and Director of Intelligent OMICS Ltd.  I also consult to A number of groups and projects around health informatics, biostatistics, environmental data analysis and artificial intelligence in image analysis.

Sponsors and collaborators

Research funding has included:

1.NIHR evaluation of the SPAG5 biomarker in the clinical setting. NIHR Co

2.Technology Strategy Board Tuberculosis. Translation of Bovine Tuberculosis biomarkers to the point of care setting. 101555.Lead by Prof Graham Ball. Total value £980K.

3. Technology Strategy Board Sepsis 2. Validation of prognostic biomarkers for Sepsis. Lead by Karen Kempsall, Health Protection Agency. Total value £1.2M.

4. MRC DPFS award (DPFSDP003) Nottingham Prognostic Index Plus (NPI+) Lead by Prof Ian Ellis, University of Nottingham. Total Value £767,375.

5. I-Net Nottingham Prognostic Index+ Lead by Prof Ian Ellis, University of Nottingham. Total Value £100,429.

6. DTI technology programme (TP/7/BIO/6/S/M0011G). Characterization of cellular stress using mass spectrometry , lead by Dr Stephen Ward, Onyvax Ltd, 2008-2011, total value £1.1M.

7. European Union Sixth Framework funded specific targeted research project. (Contract number LSH-2002-2 503306) European Network for the identification and validation of Antigens and biomarkers in Cancer and their application in clinical Tumour immunology. Principal Investigator – Dr Graham Ball. Coordinator Prof Robert Rees, School of Biomedical and Natural Sciences, Nottingham Trent University. Total Value €4.23M Euro (Grant value for my component €420K (£323K)) Start Jan 2005, End Jan 2008

8. European Union Sixth Framework funded Network of Excellence (Contract number IST-2002-1 508803) BIOPATTERN – Computational intelligence for biopattern analysis in support of eHealthcare. Principal investigator – Dr Graham Ball. Coordinator Prof Emmanuel Ifeachior – School of Computing, Communications and Electronics, University of Plymouth. Total Value €6.2M (Grant value for my component €196K(£151K) Start Jan 2005, End Jan 2008.

9. Breast cancer campaign (Contract Reference 2005nov08) -Transcriptional/Translational Analysis Of Breast Cancer Providing A Modern Clinical Classification System. Principal investigator NTU: Dr Graham Ball.  Coordinator Dr A Green, Dept of Histopathology, School of Molecular Medical Sciences, University of Nottingham. Co-applicant Prof I.O Ellis. Total Value £174,501 (Grant value for my component £18,000). Start Jan 2006, End Jan 2009

10. UK Department of Trade and Industry UK Texas Biosciences initiative. Computational and bioinformatics characterisation of microbial pathogens and their epidemiology – travel grant and linking award.  Principal investigator: Dr Graham Ball. Co-applicants: Prof Garry Adams, Prof Bo Norby and Prof Michael Ward, Texas A and M University, College Station, Texas. Total Value of Funding £18K all at Nottingham Trent. Start Jan 2006.  End Dec 2006.

11. UK landfill tax credit – Administered through Waste Recycling Environmental. (Contract). Development of composted green waste based alternative growing media.  Principal Investigator Dr Graham Ball. Co applicant: Dr William Carlile, School of Biomedical and Natural Sciences, Nottingham Trent University. Total Value £40K. Start Jan 2002 End Dec 2005.

12. East Midlands Development Agency Technology fund. Biomarker Discovery and Validation Value to NTU £476,085. Lead Applicant Yvonne Barnett. Co applicants Graham Ball and Robert Rees.

13. Alzheimer’s Research Trust. (ART/PG2008/3). Using a panel of potential CSF biomarkers for Alzheimer’s disease diagnosis. Total Value £ 213,884 Value to NTU £177,228. Co-applicants Graham Ball, Robert Rees and Balwir Matharoo-Ball. Lead Applicant Kevin Morgan.

14. Inet Biomarkers for Chronic Obstructive Pulmonary Disease Total Value £78,250 Co-applicants Graham Ball, Robert Rees and Balwir Matharoo-Ball. Lead Applicant Noor Kalsheker

15. I-Net Nottingham Prognostic Index+ Lead by Prof Ellen Billett, Nottingham Trent University. Value to NTU £62,500

16. UK food standards Agency (Contract reference Q01105) - Proteomic detection and quantification of offal in foods, Prof Ellen Billett (lead), Dr Graham Ball, Prof Colin Creaser and Dr Alan Hargreaves. Value is £285k . Start November 2006 End November 2009

17. World Anti Doping Agency. The application of cellular chemistry and proteomic approaches to the detection of gene doping. Prof. Phil Teale, Dr. Jane Roberts, Dr. Graham Ball, Prof. Colin Creaser and Prof. Geoff Goldspink. Total Value £210K NTU £90K (Joint with Prof Colin Creaser). Start Oct 2005 End Oct 2008.

18. EU objective 2 funding and Department of Trade and Industry Single Pot Funding. BEST Network. Coordinator Dr Peter Redfern, School of Biomedical and Natural Sciences, Nottingham Trent University. Total Value £3.2 million. Start Jan 2003 End Dec 2006

Publications

  1. Wagner, Sarah; Vadakekolathu, Jayakumar; Tasian, Sarah K; Altmann, Heidi; Bornhäuser, Martin; Pockley, A Graham; Ball, Graham R; Rutella, Sergio; ,A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study,Blood advances,3,8,1330-1346,2019
  2. Oral, OL; Whelehan, Patsy; Ali, Kulsam; Vinnicombe, Sarah; Ball, Graham; Cox, Julie; Farry, Paul; Jenkin, Maggie; Kapsoulis, Dimitrios; Lowry, Keith; ,British Society of Breast Radiology Annual Scientific Meeting 2018,Breast Cancer Research,20,,1,2018
  3. Whelehan, Patsy; Ali, Kulsam; Vinnicombe, Sarah; Ball, Graham; Cox, Julie; Farry, Paul; Jenkin, Maggie; Kapsoulis, Dimitrios; Lowry, Keith; McIntosh, Stuart; ,Digital breast tomosynthesis versus digital mammography (FFDM) in younger symptomatic women,BREAST CANCER RESEARCH,20,,,2018
  4. Barron, Donald; Ball, Graham; Robins, Matthew; Sunderland, Caroline; ,Artificial neural networks and player recruitment in professional soccer,PloS one,13,10,e0205818,2018
  5. Whelehan, Patsy; Ali, Kulsam; Vinnicombe, Sarah; Ball, Graham; Cox, Julie; Farry, Paul; Jenkin, Maggie; Kapsoulis, Dimitrios; Lowry, Keith; McIntosh10, Stuart; ,British Society of Breast Radiology Annual Scientific Meeting 2018,Breast Cancer Research,20,1,129,2018
  6. Thompson, Alastair M; Clements, Karen; Cheung, Shan; Pinder, Sarah E; Lawrence, Gill; Sawyer, Elinor; Kearins, Olive; Ball, Graham R; Tomlinson, Ian; Hanby, Andrew; ,Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project,European Journal of Cancer,101,,210-219,2018
  7. Maxwell, Anthony J; Clements, Karen; Hilton, Bridget; Dodwell, David J; Evans, Andrew; Kearins, Olive; Pinder, Sarah E; Thomas, Jeremy; Wallis, Matthew G; Thompson, Alastair M; ,Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ,European Journal of Surgical Oncology,44,4,429-435,2018
  8. Wagner, Sarah; Ball, Graham R; Pockley, A Graham; Miles, Amanda K; ,Application of omic technologies in cancer research,Translational Medicine Reports,2,1,,2018
  9. Martin, Stewart G; Lebot, Marie N; Sukkarn, Bhudsaban; Ball, Graham; Green, Andrew R; Rakha, Emad A; Ellis, Ian O; Storr, Sarah J; ,Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients,Oncotarget,9,40,25946,2018
  10. Rakha, Emad A; Aleskandarani, Mohamed; Toss, Michael S; Green, Andrew R; Ball, Graham; Ellis, Ian O; Dalton, Leslie W; ,Breast cancer histologic grading using digital microscopy: concordance and outcome association,Journal of clinical pathology,71,8,680-686,2018
  11. Thompson, Alastair M; Clements, Karen; Cheung, Shan; Pinder, Sarah E; Lawrence, G; Sawyer, Elinor; Kearins, Olive; Ball, Graham R; Tomlinson, Ian; Hanby, Andrew M; ,Impact of radiotherapy and endocrine therapy on further events: Final multivariate analysis of a prospective, national cohort study of screen detected ductal carcinoma in situ (DCIS) of the breast,CANCER RESEARCH,78,4,,2018
  12. Jiang, Lu; Ball, Graham; Hodgman, Charlie; Coules, Anne; Zhao, Han; Lu, Chungui; ,Analysis of gene regulatory networks of maize in response to nitrogen,Genes,9,3,151,2018
  13. Vadakekolathu, Jayakumar; Al-Juboori, Shaymaa Ismael Kadhim; Johnson, Catherine; Schneider, Anne; Buczek, Magdalena Elżbieta; Biase, Anna; Pockley, Alan Graham; Ball, Graham Roy; Powe, Desmond George; Regad, Tarik; ,MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer,Cell death & disease,9,3,344,2018
  14. Zafeiris, Dimitrios; Rutella, Sergio; Ball, Graham Roy; ,An Artificial Neural Network Integrated Pipeline for Biomarker Discovery Using Alzheimer's Disease as a Case Study,Computational and structural biotechnology journal,16,,77-87,2018
  15. Furini, Giulia; Schroeder, Nina; Huang, Linghong; Boocock, David; Scarpellini, Alessandra; Coveney, Clare; Tonoli, Elisa; Ramaswamy, Raghavendran; Ball, Graham; Verderio, Claudia; ,Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction,Journal of the American Society of Nephrology,29,3,880-905,2018
  16. Steele, Kathryn H; Macmillan, R Douglas; Ball, Graham R; Akerlund, Malin; McCulley, Stephen J; ,Multicentre study of patient-reported and clinical outcomes following immediate and delayed Autologous Breast Reconstruction And Radiotherapy (ABRAR study),Journal of Plastic, Reconstructive & Aesthetic Surgery,71,2,185-193,2018
  17. Zafeiris, Dimitrios; Vadakekolathu, Jayakumar; Wagner, Sarah; Pockley, Alan Graham; Ball, Graham Roy; Rutella, Sergio; ,Discovery and application of immune biomarkers for hematological malignancies,Expert review of molecular diagnostics,17,11,983-1000,2017,Taylor & Francis
  18. Bagnati, Marta; Ogunkolade, Babatunji W; Marshall, Catriona; Tucci, Carmen; Hanna, Katie; Jones, Tania A; Bugliani, Marco; Nedjai, Belinda; Caton, Paul W; Kieswich, Julius; ,Glucolipotoxicity initiates pancreatic β-cell death through 1 tumour necrosis factor receptor 5 (TNFR5/CD40) mediated 2 STAT1 and NF-κB activation,Cell Death and Disease,7,,e2329,2016
  19. Hanna, K; Bagnati, M; Ogunkolade, BW; Marshall, C; Bugliani, M; Marchetti, P; Caton, PW; Ball, GR; Hitman, GA; Turner, M; ,Role of tumour necrosis factor receptor 5 in glucolipotoxic islet cell death,,,,,2017,Wiley
  20. Althobiti, M; Aleskandarany, MA; Green, AR; Rodriguez, M Diez; Nolan, CC; Ball, GR; Ellis, IO; Rakha, EA; ,Zinc Finger Protein 22: a Potential Metastatic Progression Biomarker in Invasive Breast Cancer,JOURNAL OF PATHOLOGY,241,,S9-S9,2017
  21. Delpech, Pierre; Rifa, Etienne; Ball, Graham; Nidelet, Sabine; Dubois, Emeric; Gagne, Geneviève; Montel, Marie-Christine; Delbès, Céline; Bornes, Stephanie; ,New insights into the anti-pathogenic potential of Lactococcus garvieae against Staphylococcus aureus based on RNA sequencing profiling,Frontiers in microbiology,8,,359,2017
  22. Green, William JF; Ball, Graham; Hulman, Geoffrey; Johnson, Catherine; Van Schalwyk, Gerry; Ratan, Hari L; Soria, Daniel; Garibaldi, Jonathan M; Parkinson, Richard; Hulman, Joshua; ,KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach,British journal of cancer,115,2,236,2016
  23. Powe, Desmond G; Buczek, Magdalena E; Johnson, Catherine; Schneider, Anne; Vadakekolathu, Jayakumar; Ellis, Ian O; Pockley, Alan G; Rees, Robert C; Ball, Graham R; Regard, Tarik; ,Cellular pathways regulating the function of MTSS1 in HER2-positive breast cancer,INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,38,,S57-S57,2016
  24. Rakha, Emad A; Agarwal, Devika; Green, Andrew R; Ashankyty, Ibraheem; Ellis, Ian O; Ball, Graham; Alaskandarany, Mohammed A; ,Prognostic stratification of oestrogen receptor‐positive HER 2‐negative lymph node‐negative class of breast cancer,Histopathology,70,4,622-631,2017,
  25. Arora, Arvind; Parvathaneni, Swetha; Aleskandarany, Mohammed A; Agarwal, Devika; Ali, Reem; Abdel-Fatah, Tarek; Green, Andrew R; Ball, Graham R; Rakha, Emad A; Ellis, Ian O; ,Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers,Molecular cancer therapeutics,16,1,239-250,2017,American Association for Cancer Research
  26. Cornford, Eleanor J; Turnbull, Anne E; James, Jonathan J; Tsang, Rachel; Akram, Tayeba; Burrell, Helen C; Hamilton, Lisa J; Tennant, Sarah L; Bagnall, Mark J; Puri, Shama; ,Accuracy of GE digital breast tomosynthesis vs supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesions,The British journal of radiology,89,1058,20150735,2016,The British Institute of Radiology.
  27. Bagnati, Marta; Ogunkolade, Babatunji W; Marshall, Catriona; Tucci, Carmen; Hanna, Katie; Jones, Tania A; Bugliani, Marco; Nedjai, Belinda; Caton, Paul W; Kieswich, Julius; ,Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation,Cell death & disease,7,8,e2329,2016
  28. Sajid Javed, Leanne Marsay, Alice Wareham, Kuiama S. Lewandowski, Ann Williams, Michael J. Dennis, Sally Sharpe, Richard Vipond, Nigel Silman, Graham Ball, Karen E. Kempsell: Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification. PLoS ONE 07/2016; 11(7). DOI:10.1371/journal.pone.0159783 Impact Factor: 3.534 SNIP: 1.034 Citations 1
  29. Abdel-Fatah, Tarek MA; Agarwal, Devika; Liu, Dong-Xu; Russell, Roslin; Rueda, Oscar M; Liu, Karen; Xu, Bing; Moseley, Paul M; Green, Andrew R; Pockley, Alan G; ,SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis, The Lancet Oncology,17,7,1004-1018,2016
  30. William JF Green, Graham Ball, Geoffrey Hulman, Catherine Johnson, Gerry Van Schalwyk, Hari L Ratan, Daniel Soria, Jonathan M Garibaldi, Richard Parkinson, Joshua Hulman, Robert Rees, Desmond G Powe: KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach. British Journal of Cancer 06/2016; 115(2). DOI:10.1038/bjc.2016.169 Impact factor:5.569 SNIP: 1.436 Citations:0
  31. Tarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, Roslin Russell, Oscar M Rueda, Karen Liu, Bing Xu, Paul M Moseley, Andrew R Green, Alan G Pockley, Robert C Rees, Carlos Caldas, Ian O Ellis, Graham R Ball, Stephen Y T Chan: SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology 06/2016; DOI:10.1016/S1470-2045(16)00174-1 Impact factor 24.69 SNIP: 8.101 Citations:2
  32. Andrew R. Green, Daniele Soria, Desmond G. Powe, Christopher C. Nolan, Mohammed A. Aleskandarany, M.A. Szász, A.M. Tőkés, G.R. Ball, Jonathan M. Garibaldi, E. A. Rakha, J. Kulka, Ian O. Ellis: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer. Breast Cancer Research and Treatment 04/2016; 157(1). DOI:10.1007/s10549-016-3804-1 Impact Factor 3.940. SNIP: 1.248 Citations: 0
  33. Andrew R Green, Mohammed A Aleskandarany, Devika Agarwal, Somaia Elsheikh, Christopher C Nolan, Maria Diez-Rodriguez, R Douglas Macmillan, Graham R Ball, Carlos Caldas, Srinivasan Madhusudan, Ian O Ellis, Emad A Rakha: MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours. British Journal of Cancer 03/2016; DOI:10.1038/bjc.2016.46 Impact factor:5.569 SNIP: 1.436 Citations:1
  34. Mohammed A. Aleskandarany, Devika Agarwal, Ola H. Negm, Graham Ball, Ahmed Elmouna, Ibraheem Ashankyty, Edem Nuglozeh, Mohammad F. Fazaludeen, Maria Diez-Rodriguez, Christopher C. Nolan, Patrick J. Tighe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha: The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Research and Treatment 02/2016; 156(1). DOI:10.1007/s10549-016-3709-z Impact Factor 3.940. SNIP: 1.248 Citations: 0
  35. Shamanna RA, Lu H, Croteau DL, Arora A, Agarwal D, Ball G, Aleskandarany MA, Ellis IO, Madhusudan S, Bohr VA: Camptothecin-induced WRN degradation is a potential sensitivity marker for breast cancer chemotherapy. Oncotarget 02/2016; In Press. DOI:10.18632/oncotarget.7906 Impact Factor 6.359. SNIP: 1.189 Citations: 0
  36. Karen E Kempsell, Graham Ball, Tamas Szakmany: Issues in biomarker identification, validation and development for disease diagnostics in Public Health. Expert Review of Molecular Diagnostics 12/2015; DOI:10.1586/14737159.2016.1133300 Impact Factor 2.78. SNIP: 0.776 Citations: 0
  37. Arvind Arora, Devika Agarwal, Tarek MA Abdel-Fatah, Huiming Lu, Deborah L. Croteau, Paul Moseley, Mohammed A Aleskandarany, Andrew R Green, Graham Ball, Emad A Rakha, Stephen YT Chan, Ian O Ellis, Lisa L Wang, Yongliang Zhao, Adayabalam S. Balajee, Vilhelm A. Bohr, Srinivasan Madhusudan: RECQL4 helicase has oncogenic potential in sporadic breast cancers. The Journal of Pathology 12/2015; In Press(4). DOI:10.1002/path.4681 Impact factor: 7.381 SNIP: 1.781 Citations:1
  38. Eleanor J Cornford, Anne E Turnbull, Jonathan J James, Rachel Tsang, Tayeba Akram, Helen C Burrell, Lisa J Hamilton, Sarah LTennant, Mark J Bagnall, Shama Puri, Graham R Ball, Yan Chen, Vivienne Jones: Accuracy of GE digital breast tomosynthesis versus supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesions. The British journal of radiology 11/2015; 89(1058). DOI:10.1259/bjr.20150735 Impact factor: 1.184 SNIP: 1.107 Citations:0
  39. Arvind Arora, Tarek MA Abdel-Fatah, Devika Agarwal, Deborah L Croteau, Andrew Green, Emad A Rakha, Graham Ball, Stephen YT Chan, Ian O Ellis, Vilhelm A Bohr, Helen E Bryant, Srinivasan Madhusudan: Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis 11/2015; 37(1). DOI:10.1093/carcin/bgv163 Impact Factor 4.874 SNIP: 1.311 Citations: 0
  40. K Clements, D Dodwell, G Lawrence, G Ball, A Francis, S Pinder, E Sawyer, M Wallis, A.M. Thompson: Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 08/2015; 41(10). DOI:10.1016/j.ejso.2015.07.021 Impact Factor 2.94 SNIP: 1.314 Citations: 1
  41. Tarek Ma Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, Paul M Moseley, Andrew R Green, Graham R Ball, A Graham Pockley, Ian O Ellis, Robert C Rees, Stephen Yt Chan: HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: A Transcriptomic and protein expression analysis. Clinical Cancer Research 08/2015; 22(4). DOI:10.1158/1078-0432.CCR-15-0610 Impact Factor: 8.738 SNIP: 1.933 Citations:2
  42. Clare Coveney, David J Boocock, Robert C Rees, Suha Deen, Graham R Ball: Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer. Microarrays 2015, 4(3), 324-338; doi:10.3390/microarrays4030324 Impact Factor: n/a SNIP: n/a Citations:0
  43. Andrew R Green, Daniel Soria, Jacqueline Stephen, Desmond G Powe, Christopher C Nolan, Ian Kunkler, Jeremy Thomas, Gill Kerr, Wilma Jack, David Cameron, Tammy Piper, Graham R Ball, Jonathan M Garibaldi, Emad A Rakha, John MS Bartlett, Ian O Ellis: Abstract P5-09-01: Nottingham prognostic index plus (NPI+): Validation of the modern clinical decision making tool in breast cancer. Cancer Research 05/2015; 75(9 Supplement). DOI:10.1158/1538-7445.SABCS14-P5-09-01 Impact Factor: 8.556 SNIP: 1.933 Citations:34
  44. Arvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M Moseley, Mohammed A Aleskandarany, Andrew R Green, Graham Ball, Alaa T Alshareeda, Emad A Rakha, Stephen Y T Chan, Ian O Ellis, Srinivasan Madhusudan: Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics 02/2015; DOI:10.1158/1535-7163.MCT-14-0939 Impact Factor: 5.579 SNIP: 1.392 Citations: 4.
  45. KL Gale, Ea Rakha, Graham Ball, Vkm Tan, Sj McCulley, Rd Macmillan: A Case-Controlled Study of the Oncologic Safety of Fat Grafting. Plastic and Reconstructive Surgery 01/2015; 135(5). DOI:10.1097/PRS.0000000000001151 Impact Factor: 3.087 SNIP: 1.816 Citations: 10.
  46. Dong Ling Tong, Graham R. Ball, A. Graham Pockley: gEM/GANN: A multivariate computational strategy for auto-characterizing relationships between cellular and clinical phenotypes and predicting disease progression time using high-dimensional flow cytometry data: gEM/GANN. Cytometry Part A 01/2015; 87(7). DOI:10.1002/cyto.a.22622 Impact Factor: 3.181 SNIP: 0.893 Citations: 3
  47. Tarek M A Abdel-Fatah, Graham Ball, Andrew Hs Lee, Sarah E Pinder, R Douglas Macmillan, Eleanor Cornford, Paul M Moseley, Rafael Silverman, James Price, Bruce Latham, David Palmer, Arlene Chan, Ian O Ellis, Steve Chan: Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer. Clinical Cancer Research 12/2014; 21(5). DOI:10.1158/1078-0432.CCR-14-0685 Impact Factor: 8.738 SNIP: 1.933 Citations:5
  48. Tarek M.A. Abdel-Fatah, Arvind Arora, Paul Moseley, Clare Coveney, Christina Perry, Kerstie Johnson, Christopher Kent, Graham Ball, Stephen Chan, Srinivasan Madhusudan: Ataxia-telangiectasia mutated kinase (ATM), ataxia-telangiectasia mutated and Rad3 related kinase (ATR) and DNA-dependent protein kinase (DNA-PK) expression correlate to adverse clinical outcomes in human epithelial ovarian cancers..Biochimica et Biophysica Acta - Clinical 12/2014; 2(C). DOI:10.1016/j.bbacli.2014.08.001 Impact Factor: TBC SNIP:TBC Citations 1.
  49. Abdel-Fatah TMA, Fiona K Middleton, Arvind Arora, Paul M Moseley, Devika Agarwal, Christina Perry, Stephen Chan, Andrew R Green, Graham Ball, Ellis IO, Nicola J Curtin, Srinivasan Madhusudan: Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology 10/2014; In Press(3). DOI:10.1016/j.molonc.2014.10.013 Impact Factor: 5.331 SNIP: 1.23 Citations: 9
  50. Tarek Ma. Abdel-Fatah, Roslin Russell, Nada Albarakati, David J. Maloney, Dorjbal Dorjsuren, Oscar M. Rueda, Paul Moseley, Vivek Mohan, Hongmao Sun, Rachel Abbotts, Abhik Mukherjee, Devika Agarwal, Jennifer L. Illuzzi, Ajit Jadhav, Anton Simeonov, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, David M. Wilson, Srinivasan Madhusudan: Genomic and protein expression analysis reveals Flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Molecular Oncology 10/2014; DOI:10.1016/j.molonc.2014.04.009 Impact Factor: 5.331 SNIP: 1.23 Citations:17
  51. Abdel-Fatah TMA, Arvind Arora, Nouf Alsubhi, Devika Agarwal, Moseley PM, Christina Perry, Rachel Doherty, Chan SYT, Green AR, Emad Rakha, Graham Ball, Ellis IO, Srinivasan Madhusudan: Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts. Neoplasia 09/2014; 16(11). DOI:10.1016/j.neo.2014.09.009 Impact Factor: 4.509 SNIP: 1.061 Citations:8
  52. Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Roslin Russell, Devika Agarwal, Paul Moseley, Christina Perry, Arvind Arora, Nouf Alsubhi, Claire Seedhouse, Emad A. Rakha, Andrew Green, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan: Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology 08/2014; In Press. DOI:10.1016/j.molonc.2014.08.001. Impact Factor: 5.331 SNIP: 1.23 Citations:12
  53. Dong Ling Tong, David J Boocock, Gopal Krishna R Dhondalay, Christophe Lemetre, Graham R Ball: Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas. PLoS ONE 07/2014; 9(7). DOI:10.1371/journal.pone.0102483 Impact Factor: 3.534 SNIP: 1.034 Citations:4
  54. Christina Perry, Devika Agarwal, Tarek M.A. Abdel-Fatah, Anbarasu Lourdusamy, Richard Grundy, Dorothee T Auer, David Walker, Ravi Lakhani, Ian S Scott, Stephen Chan, Graham Ball, Srinivasan Madhusudan: Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era. Oncotarget 07/2014; DOI:10.18632/oncotarget.2180 Impact Factor 6.359. SNIP: 1.189 Citations: 4
  55. Gopal Krishna Dhondalay, Katherine Lawrence, Stephen Ward, Graham Ball, Michael Hoare: Relationship between preparation of cells for therapy and cell quality using Artificial Neural Network analysis. Artificial Intelligence in Medicine 07/2014; 62(2). DOI:10.1016/j.artmed.2014.07.003 Impact factor: 1.355 SNIP: 1.869 Citations:3
  56. Jeremy Thomas, Andrew Hanby, Sarah E. Pinder, Graham Ball, Gill Lawrence, Anthony Maxwell, Matthew Wallis, Andrew Evans, Hilary Dobson, Karen Clements, Alastair Thompson: Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. European Journal of Cancer 07/2014; 50(11). DOI:10.1016/j.ejca.2014.02.023 Impact Factor: 6.163 SNIP: 2.010 Citations:5
  57. Tarek Abdel-Fatah, Arvind Arora, Devika Agarwal, Paul Moseley, Christina Perry, Nicola Thompson, Andrew R Green, Emad Rakha, Stephen Chan, Graham Ball, Ian O Ellis, Srinivasan Madhusudan: Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment 06/2014; 146(2). DOI:10.1007/s10549-014-3035-2 Impact Factor 3.940. SNIP: 1.248 Citations: 4
  58. John Okyere, Ekow Oppon, Daniel Dzidzienyo, Lav Sharma, Graham Ball: Cross-Species Gene Expression Analysis of Species Specific Differences in the Preclinical Assessment of Pharmaceutical Compounds. PLoS ONE 05/2014; 9(5). DOI:10.1371/journal.pone.0096853 Impact Factor: 3.534 SNIP: 1.034 Citations:5
  59. Rachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, David J Maloney, Anton Simeonov, Claire Seedhouse, Faye Elliott, Jon Laye, Christy Walker, Ajit Jadhav, Anna Grabowska, Graham Ball, Poulam M Patel, Julia Newton-Bishop, David M Wilson, Srinivasan Madhusudan: Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy. Oncotarget 04/2014; 5(10). DOI:10.18632/oncotarget.1926 Impact Factor 6.359. SNIP: 1.189 Citations: 0
  60. T M A Abdel-Fatah, S E B McArdle, C Johnson, P M Moseley, G R Ball, A G Pockley, I O Ellis, R C Rees, S Y T Chan: HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer 04/2014; 110(10). DOI:10.1038/bjc.2014.168 Impact factor:5.569 SNIP: 1.436 Citations:10
  61. S. Madhusudan, TMA Abdel-Fatah, R. Russell, P. Moseley, D. Agarwal, A. Mukherjee, G. Ball, R. Abbotts, C. Perry, C. Caldas, EA Rakha, S. Chan, IO Ellis: Abstract P3-04-01: Discovery of distinct sub-groups of ER positive breast cancers by DNA repair expression profiling: Implications for patient stratification and personalization of therapy. Cancer Research 03/2014; 73(24 Supplement). DOI:10.1158/0008-5472.SABCS13-P3-04-01 Impact Factor: 8.556 SNIP: 1.933 Citations:0
  62. EA Rakha, Daniele Soria, AR Green, Christophe Lemetre, Desmond G. Powe, Christopher C. Nolan, Jonathan M. Garibaldi, Graham Ball, Ian O. Ellis: Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. British Journal of Cancer 03/2014; 110(7). DOI:10.1038/bjc.2014.120 Impact factor:5.569 SNIP: 1.436 Citations:34
  63. Ailbhe M McDermott, Nicola Miller, Deirdre Wall, Lorcan M Martyn, Graham Ball, Karl J Sweeney, Michael J Kerin: Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer. PLoS ONE 01/2014; 9(1). DOI:10.1371/journal.pone.0087032 Impact Factor: 3.534 SNIP: 1.034 Citations:35
  64. Tarek M.A. Abdel-Fatah, Roslin Russell, Devika Agarwal, Paul Moseley, Michael Ayotunde Abayomi, Christina Perry, Nada Albarakati, Graham Ball, Stephen Chan, Carlos Caldas, Ian O Ellis, Srinivasan Madhusudan: DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts. Molecular oncology 01/2014; 8(3). DOI:10.1016/j.molonc.2014.01.001 Impact Factor: 5.331 SNIP: 1.23 Citations:14
  65. Desmond G Powe, Gopal Krishna R Dhondalay, Christophe Lemetre, Tony Allen, Hany O Habashy, Ian O Ellis, Robert Rees, Graham R Ball: DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer. PLoS ONE 01/2014; 9(1). DOI:10.1371/journal.pone.0084428 Impact Factor: 3.534 SNIP: 1.034 Citations:13
  66. Tarek M A Abdel-Fatah, Nada Albarakati, Lara Bowell, Devika Agarwal, Paul Moseley, Claire Hawkes, Graham Ball, Stephen Chan, Ian O Ellis, Srinivasan Madhusudan: Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Research and Treatment 11/2013; 142(3). DOI:10.1007/s10549-013-2769-6 Impact Factor 3.940. SNIP: 1.248 Citations: 10
  67. A R Green, D G Powe, E A Rakha, D Soria, C Lemetre, C C Nolan, F F T Barros, R D Macmillan, J M Garibaldi, G R Ball, I O Ellis: Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer 09/2013; 109(7). DOI:10.1038/bjc.2013.528 Impact factor:5.569 SNIP: 1.436 Citations:21
  68. T M A Abdel-Fatah, C Perry, P Dickinson, G Ball, P Moseley, S Madhusudan, I O Ellis, S Y T Chan: Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology 08/2013; 24(11). DOI:10.1093/annonc/mdt277 Impact Factor: 9.269 SNIP: 2.32 Citations:37
  69. Itaru Dekio, Renata Culak, Min Fang, Graham Ball, Saheer Gharbia, Haroun N Shah: Correlation between Phylogroups and Intracellular Proteomes of Propionibacterium acnes and Differences in the Protein Expression Profiles between Anaerobically and Aerobically Grown Cells. BioMed Research International. Volume 2013 (2013), Article ID 151797, DOI:10.1155/2013/151797 Impact Factor: 2.134 SNIP: 0.576 Citations:11
  70. Daniele Soria, Jonathan M Garibaldi, Andrew R Green, Desmond G Powe, Christopher C Nolan, Christophe Lemetre, Graham R Ball, Ian O Ellis: A quantifier-based fuzzy classification system for breast cancer patients. Artificial intelligence in medicine 06/2013; 58(3). DOI:10.1016/j.artmed.2013.04.006 Impact factor: 1.355 SNIP: 1.869 Citations:10
  71. Mohammad Ilyas, Heike Grabsch, Ian O Ellis, Chris Womack, Robert Brown, Dan Berney, Dean Fennell, Manuel Salto-Tellez, Martin Jenkins, Goran Landberg, Richard Byers, Darren Treanor, David Harrison, Andrew R Green, Graham Ball, Peter Hamilton: Guidelines and considerations for conducting experiments using tissue microarrays. Histopathology 05/2013; 62(6). DOI:10.1111/his.12118 Impact Factor:3.425 SNIP: 1.219 Citations:26
  72. M. Sundquist, G. Ball, B. H. Stenstam: The Importance Of Mathematics In Breast Cancer Treatment. The Breast 03/2013; 22. Impact Factor:1.92 SNIP: 0.872 Citations:0
  73. Liana E Kafetzopoulou, David J Boocock, Gopal Krishna R Dhondalay, Desmond G Powe, Graham R Ball: Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response. Computational and Structural Biotechnology Journal 03/2013; 6(7). DOI:10.5936/csbj.201303003 Impact Factor:n/a SNIP: n/a Citations:5
  74. Stéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, Geng Li, Amanda K Miles, David C Hughes, Graham R Ball, Ian O Ellis, Angelos D Gritzapis, Ioannis Missitzis, Stéphanie E B McArdle, Robert C Rees: Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells. Genes Chromosomes and Cancer 03/2013; 52(3). DOI:10.1002/gcc.22031 Impact factor: n/a SNIP: n/a Citations: 2
  75. Yu Pan, Glyn Bradley, Kevin Pyke, Graham Ball, Chungui Lu, Rupert Fray, Alexandra Marshall, Subhalai Jayasuta, Charles Baxter, Rik van Wijk, Laurie Boyden, Rebecca Cade, Natalie H Chapman, Paul Faser, Charlie Hodgman, Graham B Seymour: Network Inference Analysis Identifies an APRR2-Like Gene Linked to Pigment Accumulation in Tomato and Pepper Fruits. Plant physiology 01/2013; 161(3). DOI:10.1104/pp.112.212654 Impact Factor:8.030 SNIP: 1.919 Citations: 32.
  76. S. Ehsan, G. Ball, E. Choke, K. M. Molyneux, N. J. M. London, K. E. Herbert, J. Barratt, R. D. Sayers, M. J. Bown: Disease Specific Biomarkers of Abdominal Aortic Aneurysms Detected by Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry. European Journal of Vascular and Endovascular Surgery 01/2013; 45(1). DOI:10.1016/j.ejvs.2012.10.007 Impact Factor:2.490 SNIP: 1.705 Citations:6
  77. Rebeka Sultana, Tarek Abdel-Fatah, Rachel Abbotts, Claire Hawkes, Nada Albarakati, Claire H Seedhouse, Graham Ball, Stephen Chan, Emad A Rakha, Ian O Ellis, Srinivasan Madhusudan: Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy. Cancer Research 12/2012; 73(5). DOI:10.1158/0008-5472.CAN-12-2929 Impact Factor: 8.556 SNIP: 1.933 Citations:32
  78. TMA Abdel-Fatah, G. Balls, AK Miles, P. Moseley, A. Green, R. Rees, IO Ellis, SYT Chan: Abstract P6-07-09: Identification of Trophinin associated protein (TROAP) as a novel biological marker in breast cancer (BC): Co-expression of TROAP and TOPO2A predicts response of anthracycline based chemotherapy (ATC-CT). Cancer Research 12/2012; 72(24 Supplement). DOI:10.1158/0008-5472.SABCS12-P6-07-09 Impact Factor: 8.556 SNIP: 1.933 Citations:1
  79. TMA Abdel-Fatah, G. Ball, AK Miles, P. Moseley, A. Green, B. Rees, IO Ellis, SYT Chan: Abstract P6-07-18: Identification of Sperm Associated Antigen 5 (SPAG5) as a novel biological and predictive biomarker in Breast cancer. Cancer Research 12/2012; 72(24 Supplement). DOI:10.1158/0008-5472.SABCS12-P6-07-18 Impact Factor: 8.556 SNIP: 1.933 Citations:3
  80. AM McDermott, N. Miller, G. Ball, KJ Sweeney, MJ Kerin: Abstract P5-10-07: Luminal A breast cancer: identification of novel circulating miRNA biomarkers:. Cancer Research 12/2012; 72(24 Supplement). DOI:10.1158/0008-5472.SABCS12-P5-10-07 Impact Factor: 8.556 SNIP: 1.933 Citations:0
  81. B G Baker, G R Ball, E A Rakha, C C Nolan, C Caldas, I O Ellis, A R Green: Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast Cancer Research and Treatment 12/2012; 137(1). DOI:10.1007/s10549-012-2302-3 Impact Factor 3.940. SNIP: 1.248 Citations: 4
  82. R. Sultana, T. Abdel-Fatah, N. Albarakati, R. Abbotts, C. Seedhouse, G. Ball, S. Chan, E. Rakha, I. Ellis, S. Madhusudan: 275 Targeting XRCC1 (X-ray Repair Cross-complementing Gene 1), a Key DNA Base Excision Repair Protein for Personalized Therapy in Breast and Ovarian Cancer. European Journal of Cancer 11/2012; 48. DOI:10.1016/S0959-8049(12)72073-7 Impact Factor: 6.163 SNIP: 2.010 Citations:1
  83. Mohammed A Aleskandarany, Ola H Negm, Emad A Rakha, Mohamed A H Ahmed, Christopher C Nolan, Graham R Ball, Carlos Caldas, Andrew R Green, Patrick J Tighe, Ian O Ellis: TOMM34 Expression in Early Invasive Breast Cancer: a Biomarker Associated With Poor Outcome. Breast Cancer Research and Treatment 10/2012; 136(2). DOI:10.1007/s10549-012-2249-4 Impact Factor 3.940. SNIP: 1.248 Citations: 11
  84. J. Dorairaj, D. Wall, J. Newell, K. Sweeney, R. Blamey, G. Ball, M. J. Kerin: Galway Index of Survival (GAINS): A Validation Study. Irish Journal of Medical Science 09/2012; 181. Impact Factor: 0.573 SNIP: n/a Citations:0
  85. Elrasheid A H Kheirelseid, Nicola Miller, Kah Hoong Chang, Catherine Curran, Emer Hennessey, Margaret Sheehan, John Newell, Christophe Lemetre, Graham Balls, Michael J Kerin: MiRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. International Journal of Colorectal Disease 08/2012; 28(2). DOI:10.1007/s00384-012-1549-9 Impact factor:2.449 SNIP:1.124 Citations: 32
  86. A.M. McDermott, N. Miller, G. Ball, K.J. Sweeney, M.J. Kerin: Identification of Novel MicroRNA Biomarkers for Detection of Luminal a Breast Cancer. European Journal of Cancer 07/2012; 48. DOI:10.1016/S0959-8049(12)71488-0 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  87. S Ehsan, G Ball, E Choke, K M Molyneux, N J M London, K E Herbert, J Barratt, R D Sayers, M J Bown: Corrigendum to “Disease Specific Biomarkers of Abdominal Aortic Aneurysms Detected by Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry” [Eur J Vasc Endovasc Surg 44 (2012) 52–54]. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 05/2012; 44(1). DOI:10.1016/j.ejvs.2012.04.018 Impact Factor: 2.490 SNIP:0.112 Citations:0
  88. M G Wallis, K Clements, O Kearins, G Ball, J Macartney, G M Lawrence: The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. British Journal of Cancer 04/2012; 106(10). DOI:10.1038/bjc.2012.151 Impact factor:5.569 SNIP: 1.436 Citations:29
  89. A.M. McDermott, N. Miller, K. J. Sweeney, G. Ball, M. J. Kerin: Identification and validation of novel microRNA oncologic biomarkers of Luminal-A breast cancer. Irish Journal of Medical Science 03/2012; 181. Impact Factor: 0.573 SNIP: n/a Citations:0
  90. TMA Abdel-Fatah, MB Lambros, R. Vatcheva, G. Ball, PD Dickinson, P. Moseley, AR Green, IO Ellis, JS Reis-Filho, S. Chan: P1-06-14: Topoisomerase II alpha (Top2a) Protein Expression Is a Predictor for Response to Anthracycline-Based Chemotherapy (ATC-CT): Is It Due to Gene Amplification, HER2-Coamplification or a Summation of Pathways Leading to This Highly Proliferative Phenotype?. Cancer Research 02/2012; 71(24 Supplement). DOI:10.1158/0008-5472.SABCS11-P1-06-14 Impact Factor: 8.556 SNIP: 1.933 Citations:0
  91. TMA Abde-Fatah, P. M. Mosley, A. Lee, G. Balls, I. O. Ellis, S. Y. Chan: P1-06-17: A New Pathological Response Index (PRI) for Neoadjuvant Chemotherapy Accurately Predicts Clinical Outcomes of Locally Advanced Breast Cancers (LAPBC).. Cancer Research 02/2012; 71(24 Supplement). DOI:10.1158/0008-5472.SABCS11-P1-06-17 Impact Factor: 8.556 SNIP: 1.933 Citations:0
  92. JJ Dorairaj, D. Wall, J. Newell, RW Blamey, KJ Sweeney, G. Ball, MJ Kerin: P2-12-15: GAINS: A Breast Cancer Prognostic Index Utilizing Lymph Node Ratio.. Cancer Research 02/2012; 71(24 Supplement). DOI:10.1158/0008-5472.SABCS11-P2-12-15 Impact Factor: 8.556 SNIP: 1.933 Citations:0
  93. R.M. Hobson, B Saunders, G Ball, R.C. Harris, C Sale: Effects of β-Alanine supplementation on exercise performance: a meta-analysis. Amino Acids 01/2012; 43(1). DOI:10.1007/s00726-011-1200-z Impact Factor: 3.293. SNIP: 1.006 Citations: 127.
  94. Caroline M. Woolston, Graham Ball, Sarah J. Storr, Yimin Zhang, Ian O. Ellis, David A. L. Morgan, Stewart G. Martin: Redox protein profiling in breast cancer: predicting radiotherapeutic response. Mutagenesis 01/2012; 27(1). Impact Factor: 2.793. SNIP: 1.371 Citations: 0
  95. TMA Abdel-Fatah, AR Green, C Lemetre, P Moseley, S Chan, IO Ellis, G Balls: P4-09-11: Kinesin Family Member 2C (KIF2C) Is a New Surrogate Prognostic Marker in Breast Cancer (BC).. Cancer Research 12/2011; 71(24 Supplement). DOI:10.1158/0008-5472.SABCS11-P4-09-11 Impact Factor: 2.793. SNIP: 1.371 Citations:
  96. Abeer M Shaaban, Graham R Ball, Rebecca A Brannan, Gabor Cserni, Anna Di Benedetto, Jo Dent, Laura Fulford, Helen Honarpisheh, Lee Jordan, J Louise Jones, Rani Kanthan, Loaie Maraqa, Maria Litwiniuk, Marcella Mottolese, Steven Pollock, Elena Provenzano, Philip R Quinlan, Georgina Reall, Sami Shousha, Mark Stephens, Eldo T Verghese, Rosemary A Walker, Andrew M Hanby, Valerie Speirs: A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Research and Treatment 11/2011; 133(3). DOI:10.1007/s10549-011-1856-9 Impact Factor 3.940. SNIP: 1.248 Citations: 0
  97. Baharak Vafadar-Isfahani, Graham Ball, Clare Coveney, Christophe Lemetre, David Boocock, Lennart Minthon, Oskar Hansson, Amanda Kathleen Miles, Sabina M Janciauskiene, Donald Warden, A David Smith, Gordon Wilcock, Noor Kalsheker, Robert Rees, Balwir Matharoo-Ball, Kevin Morgan: Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid. Journal of Alzheimer's disease: JAD 11/2011; 28(3). DOI:10.3233/JAD-2011-111505 Impact Factor: 3.920 SNIP: 0.995 Citations: 12.

  1. Dong L Tong, David J Boocock, Clare Coveney, Jaimy Saif, Susana G Gomez, Sergio Querol, Robert Rees, Graham R Ball: A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: Stem cell and melanoma cancer studies. Clinical Proteomics 09/2011; 8(1). DOI:10.1186/1559-0275-8-14 Impact factor: 3.476 SNIP: 0.727 Citations: 2.
  2. J. J. Dorairaj, D. Wall, G. Ball, J. Newell, M. J. Kerin: Lymph nodal ratio as a breast cancer prognostic indicator. Irish Journal of Medical Science 09/2011; 180. Impact Factor: 0.573 SNIP: n/a Citations:
  3. Kah Hoong Chang, Nicola Miller, Elrasheid A H Kheirelseid, Christophe Lemetre, Graham R Ball, Myles J Smith, Mark Regan, Oliver J McAnena, Michael J Kerin: MicroRNA signature analysis in colorectal cancer: Identification of expression profiles in stage II tumors associated with aggressive disease. International Journal of Colorectal Disease 07/2011; 26(11). DOI:10.1007/s00384-011-1279-4 Impact factor:2.449 SNIP:1.124 Citations: 0
  4. Hany Onsy Habashy, Desmond G Powe, Enrico Glaab, Graham Ball, Inmaculada Spiteri, Natalio Krasnogor, Jonathan M Garibaldi, Emad A Rakha, Andrew R Green, C Caldas, Ian O Ellis: RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: A marker of ER-positive luminal-like subtype. Breast Cancer Research and Treatment 07/2011; 128(2). DOI:10.1007/s10549-010-1073-y Impact Factor 3.940. SNIP: 1.248 Citations: 0
  5. J.C. Mhlanga, A.E. Evans, S Doyle, J.J. James, E.J. Cornford, G Balls, S.Y. Chan, I Ellis: The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer. Breast 05/2011; 20(5). DOI:10.1016/j.breast.2011.04.011 Impact Factor 2.740. SNIP: 1.093 Citations: 0
  6. Matthew Wallis, K. Clements, O. Kearins, G. Ball, J. Macartney, G. Lawrence: First Non-contra-lateral Events After 15-year Follow-up of Screen-detected DCIS. European Journal of Surgical Oncology 05/2011; 37(5). DOI:10.1016/j.ejso.2011.03.075 Impact Factor 2.94 SNIP: 1.314 Citations: 0
  7. Sarah J Storr, Rabab A.A. Mohammed, Caroline M Woolston, Andrew R Green, Tim Parr, Inmaculada Spiteri, Carlos Caldas, Graham R Ball, Ian O Ellis, Stewart G Martin: Calpastatin is associated with lymphovascular invasion in breast cancer. Breast 04/2011; 20(5). DOI:10.1016/j.breast.2011.04.00 Impact Factor 2.740. SNIP: 1.093 Citations: 0
  8. Haroun N Shah, Lakshani Rajakaruna, Graham Ball, Raju Misra, Ali Al-Shahib, Min Fang, Saheer E Gharbia: Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF Mass Spectrometry and Artificial Neural Network Analysis. Systematic and Applied Microbiology 02/2011; 34(1). DOI:10.1016/j.syapm.2010.11.002 Impact factor:3.691 SNIP:1.288 Citations: 0
  9. H O Habashy, D G Powe, E Glaab, N Krasnogor, J M Garibaldi, E A Rakha, G Ball, A R Green, C Caldas, I O Ellis: RERG (Ras-related and oestrogen-regulated growth-inhibitor) expression in breast cancer: A marker of ER-positive luminal-like subtype. Breast Cancer Research and Treatment 01/2011; 128(2). Impact Factor 3.940. SNIP: 1.248 Citations: 0
  10. Tarek M A Abdel-Fatah, Desmond G Powe, Graham Ball, Maria A Lopez-Garcia, Hany O Habashy, Andrew R Green, Jorge S Reis-Filho, Ian O Ellis: Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. The Journal of Pathology 12/2010; 222(4). DOI:10.1002/path.2775 Impact factor: 7.381 SNIP: 1.781 Citations:0
  11. M Hall, G Ball, P Bosio, S Carr, N Brunskill: An early pregnancy urinary proteomic fingerprint accurately predicts later pre-eclampsia. Archives of Disease in Childhood - Fetal and Neonatal Edition 11/2010; 95(1). DOI:10.1136/adc.2010.192310.2.1 Impact factor: 3.231 SNIP: n/a Citations:0
  12. L. Cataliotti, M. Sundquist, R. Mansel, G.R. Ball: O-79 Effect of Lymphovascular Invasion (LVI) on Local Recurrence after Wide Local Excision (WLE) and after Mastectomy (Mx). EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.080 Impact Factor: 6.163 SNIP: 2.010 Citations:
  13. G.R. Ball, E. A. Rakha, D.G. Powe, C. Caldas, I.O. Ellis, A. R. Green: O-37 SOX11 and PSMD3 expression in HER2 positive breast cancer. EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.038 Impact Factor: 6.163 SNIP: 2.010 Citations:
  14. G. Ball, I. O. Ellis: O-20 Rates of growth of breast cancer. EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.021 Impact Factor: 6.163 SNIP: 2.010 Citations:
  15. M. Sundquist, S. Bianchi, A. Douglas-Jones, I. O. Ellis, A. H. S. Lee, S. Pinder, S. Thorstenson, G. R. Ball: O-68 The effect of lymphovascular invasion (LVI) on survival. EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.069 Impact Factor: 6.163 SNIP: 2.010 Citations:
  16. Andy Sutton, Robert Rees, Graham Ball: O-33 An artificial neural network based algorithm for predicting continuous time to event data in breast cancer. EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.034 Impact Factor: 6.163 SNIP: 2.010 Citations:
  17. Lee James Lancashire, Graham Roy Ball: O-22 A novel Artificial Neural Network based algorithm to analyse the interaction patterns existing in gene microarrays: An application to breast cancer genomic data. EJC Supplements 09/2010; 8(6). DOI:10.1016/j.ejcsup.2010.06.023 Impact Factor: 6.163 SNIP: 2.010 Citations:
  18. Baharak Vafadar-Isfahani, Stephanie Anne-Sophie Laversin, Murrium Ahmad, Graham Ball, Clare Coveney, Christophe Lemetre, Amanda Kathleen Miles, Gerhard van Schalkwyk, Robert Rees, Balwir Matharoo-Ball: Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model. Proteomics - Clinical Applications 09/2010; 4(8-9). DOI:10.1002/prca.200900218 Impact Factor: 2.959 SNIP: 0.602 Citations:
  19. R.W. Blamey, B. Hornmark-Stenstam, G. Ball, M. Blichert-Toft, L. Cataliotti, A. Fourquet, J. Gee, K. Holli, R. Jakesz, M. Kerin, R. Mansel, R. Nicholson, T. Pienkowski, S. Pinder, M. Sundquist, M. van de Vijver, I. Ellis: Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71]. European Journal of Cancer 06/2010; 46(9). DOI:10.1016/j.ejca.2010.03.004 Impact Factor: 6.163 SNIP: 2.010 Citations:
  20. C. M. Woolston, L Zhang, H Evans, A Al-Attar, M Shehata, G Balls, SY Chan, S. G. Martin: Thioredoxin and related redox systems as targets in breast cancer. Breast Cancer Research 05/2010; 12(Suppl 1). DOI:10.1186/bcr2526 Impact factor:5.211 SNIP:1.47 Citations: 0
  21. V Speirs, G Ball: Male versus female breast cancer: a comparative study of 523 matched cases reveals differences behind similarity. Breast cancer research: BCR 05/2010; 12 Suppl 1(Suppl 1). DOI:10.1186/bcr2492 Impact factor:5.211 SNIP:1.47 Citations: 0
  22. Hany Onsy Habashy, Desmond G. Powe, Emad A. Rakha, Graham Ball, R. Douglas Macmillan, Andrew R. Green, Ian O. Ellis: The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment 04/2010; 120(3). DOI:10.1007/s10549-009-0419-9 Impact Factor 3.940. SNIP: 1.248 Citations: 0
  23. Christopher Medway, Hui Shi, James Bullock, Holly Black, Kristelle Brown, Baharak Vafadar-Isfahani, Balwir Matharoo-Ball, Graham Ball, Robert Rees, Noor Kalsheker, Kevin Morgan: Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease. International Journal of Molecular Epidemiology and Genetics 03/2010; 1(2). Impact Factor 1.19. SNIP: n/a Citations: 0
  24. J. Lundin, K. Holli, M. Lundin, B. Hornmark-Stenstam, G. Ball, R. Blamey: 146 ONCOPOOL, a comparison with SEER. EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70177-4 Impact Factor: 6.163 SNIP: 2.010 Citations:
  25. R. Blamey, B. Hornmark-Stenstam, S. Bianchi, T. Kuukasjarvi, S. Pinder, F. Rank, G. Ball, I. Ellis: 145 A rescoring of Elston-Ellis Grade improves prognostic discrimination and consistency. EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70176-2 Impact Factor: 6.163 SNIP: 2.010 Citations:
  26. L. Cataliotti, M. Sundquist, R. Blamey, R. Mansel, G. Ball: 153 Effect of lymphovascular invasion (LVI) on local recurrence after wide local excision (WLE) and after mastectomy (Mx). EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70184-1 Impact Factor: 6.163 SNIP: 2.010 Citations:
  27. G. Ball, I. O. Ellis, A. Green, R. Blamey: 115 HER2 (cerbB2) positivity: cross correlations, and effect on survival of a pre-Herceptin treated group. EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70146-4 Impact Factor: 6.163 SNIP: 2.010 Citations:
  28. M. Sundquist, S. Bianchi, A. Douglas-Jones, I. Ellis, A. Lee, S. Pinder, S. Thorstenson, G. Ball, R. Blamey: 125 The effect of lymphovascular invasion (LVI) on survival. EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70156-7 Impact Factor: 6.163 SNIP: 2.010 Citations:
  29. H. O. Habashy, D. G. Powe, G. Ball, E. Glaab, D. Soria, J. Garibaldi, N. Krasnogor, A. R. Green, C. Caldas, I. O. Ellis: 112 Luminal-like oestrogen receptor-positive breast cancer: identification of prognostic biological subclasses. EJC Supplements 03/2010; 8(3). DOI:10.1016/S1359-6349(10)70143-9 Impact Factor: 6.163 SNIP: 2.010 Citations:
  30. Daniele Soria, Jonathan M Garibaldi, Federico Ambrogi, Andrew R Green, Des Powe, Emad Rakha, R Douglas Macmillan, Roger W Blamey, Graham Ball, Paulo J.G. Lisboa, Terence A Etchells, Patrizia Boracchi, Elia M. Biganzoli, Ian O Ellis: A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients. Computers in Biology and Medicine 03/2010; 40(3). DOI:10.1016/j.compbiomed.2010.01.003 Impact Factor: 1.521 SNIP: 1.207 Citations:
  31. R G Kay, C Barton, C P Velloso, P R Brown, C Bartlett, A J Blazevich, R J Godfrey, G Goldspink, R Rees, G R Ball, D A Cowan, S D Harridge, J Roberts, P Teale, C S Creaser: High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Communications in Mass Spectrometry 10/2009; 23(19). DOI:10.1002/rcm.4237 Impact Factor: 2.226 SNIP: 0.836 Citations:45
  32. Roger W McGilvray, Robert A Eagle, Nicholas F S Watson, Ahmad Al-Attar, Graham Ball, Insiya Jafferji, John Trowsdale, Lindy G Durrant: NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting. Clinical Cancer Research 10/2009; 15(22). DOI:10.1158/1078-0432.CCR-09-0991 Impact Factor: 8.738 SNIP: 1.933 Citations:92
  33. R.W. Blamey, B Hornmark-Stenstam, G Ball, M Blichert-Toft, L Cataliotti, A Fourquet, J Gee, K Holli, R Jakesz, M Kerin, R Mansel, R Nicholson, T Pienkowski, S Pinder, M Sundquist, M van de Vijver, I Ellis: ONCOPOOL - a European database for 16,944 cases of breast cancer. European journal of cancer (Oxford, England: 1990) 10/2009; 46(1). DOI:10.1016/j.ejca.2009.09.009 Impact Factor: 6.163 SNIP: 2.010 Citations:62
  34. T. M. A. Abdel-Fatah, D. G. Powe, G. Ball, J. S. Reis-Filho, I. O. Ellis: 5015 The need for a biological grading system and its relationship to the current Nottingham histological grading system (NGS). EJC Supplements 09/2009; 7(2). DOI:10.1016/S1359-6349(09)70907-3 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  35. Joshua Boateng, Richard Kay, Lee Lancashire, Pamela Brown, Cristiana Velloso, Pierre Bouloux, Phil Teale, Jane Roberts, Robert Rees, Graham Ball, Stephen Harridge, Geoffrey Goldspink, Colin Creaser: A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans. Proteomics - Clinical Applications 08/2009; 3(8). DOI:10.1002/prca.200800190 Impact Factor: 2.959 SNIP: 0.602 Citations:6
  36. Lakshani Rajakaruna, Gillian Hallas, Linda Molenaar, Diane Dare, Helen Sutton, Vesela Encheva, Renata Culak, Ingrid Innes, Graham Ball, Armine M Sefton, Melvin Eydmann, Angela M Kearns, Haroun N Shah: High throughput identification of clinical isolates of Staphylococcus aureus using MALDI-TOF-MS of intact cells. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 08/2009; 9(4). DOI:10.1016/j.meegid.2009.01.012 Impact Factor: 2.591 SNIP: 1.036 Citations:54
  37. H Zhang, E A Rakha, G R Ball, I Spiteri, M Aleskandarany, E C Paish, D G Powe, R D Macmillan, C Caldas, I O Ellis, A R Green: The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment 07/2009; 121(1). DOI:10.1007/s10549-009-0450-x Impact Factor 3.940. SNIP: 1.248 Citations: 38
  38. Aoife J Lowery, Nicola Miller, Amanda Devaney, Roisin E McNeill, Pamela A Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J Kerin: MicroRNA signatures predict estrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast cancer research: BCR 06/2009; 11(3). DOI:10.1186/bcr2257 Impact factor:5.211 SNIP:1.47 Citations: 282
  39. Somaia E Elsheikh, Andrew R Green, Emad A Rakha, Des G Powe, Rabab A Ahmed, Hilary M Collins, Daniele Soria, Jonathan M Garibaldi, Claire E Paish, Amr A Ammar, Matthew J Grainge, Graham R Ball, Magdy K Abdelghany, Luisa Martinez-Pomares, David M Heery, Ian O Ellis: Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM et al.. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69: 3802-3809. Cancer Research 05/2009; 69(9). DOI:10.1158/0008-5472.CAN-08-3907 Impact Factor: 8.556 SNIP: 1.933 Citations:220
  40. L J Lancashire, D G Powe, J S Reis-Filho, E Rakha, C Lemetre, B Weigelt, T M Abdel-Fatah, A R Green, R Mukta, R Blamey, E C Paish, R C Rees, I O Ellis, G R Ball: A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast Cancer Research and Treatment 05/2009; 120(1). DOI:10.1007/s10549-009-0378-1 Impact Factor 3.940. SNIP: 1.248 Citations: 57
  41. Lee J Lancashire, Christophe Lemetre, Graham R Ball: An introduction to artificial neural networks in bioinformatics - Application to complex microarray and mass spectrometry datasets in cancer studies. Briefings in Bioinformatics 04/2009; 10(3). DOI:10.1093/bib/bbp012 Impact Factor 8.399. SNIP: 2.068 Citations: 72
  42. R.G. Kay, C. Barton, C.P. Velloso, P R Brown, C. Bartlett, Anthony Blazevich, R.J. Godfrey, G. Goldspink, R Rees, G.R. Ball, D A Cowan, S.D. Harridge, J. Roberts, P Teale, C S Creaser: A high-throughput uHPLC-MS/MS quantitation of insulin-like-growth factor-1 and leucine-rich a-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Communications in Mass Spectrometry. 2009 Oct;23(19):3173-82. doi: 10.1002/rcm.4237. Impact Factor: 2.226 SNIP: 0.836 Citations:0
  43. Susan Liddell, Sabrina Dyall, Balwir Matharoo-Ball: The 7th East Midlands Proteomics Workshop 12 November 2008, Nottingham, UK. Proteomics 04/2009; 9(7). DOI:10.1002/pmic.200900026 Impact Factor: 4.079 SNIP: 0.915 Citations:0
  44. Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka, Emad A. Rakha, Graham Ball, Andrew R. Green, Mohammed Aleskandarany, E. Claire Paish, R. Douglas Macmillan, Robert I. Nicholson, Ian O. Ellis, Julia M. W. Gee: Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment 02/2009; 119(2). DOI:10.1007/s10549-009-0345-x Impact Factor 3.940. SNIP: 1.248 Citations: 84
  45. B Matharoo-Ball, AK Miles, C S Creaser, G Ball, R Rees: Serum biomarker profiling in cancer studies: A question of standardisation?. Veterinary and Comparative Oncology 01/2009; 6(4). DOI:10.1111/j.1476-5829.2008.00171.x Impact Factor 2.452. SNIP: 1.275 Citations: 18
  46. S Taneja, A.J. Evans, E.A. Rakha, A.R. Green, G Ball, I.O. Ellis: The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. Clinical Radiology 12/2008; 63(11). DOI:10.1016/j.crad.2008.06.006 Impact Factor 2.151. SNIP: 1.164 Citations: 15
  47. Hany Onsy Habashy, Desmond G Powe, Emad A Rakha, Graham Ball, Claire Paish, Julia Gee, Robert I Nicholson, Ian O Ellis: Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer 08/2008; 44(11). DOI:10.1016/j.ejca.2008.04.020 Impact Factor: 6.163 SNIP: 2.010 Citations:79
  48. Lee J Lancashire, Robert C Rees, Graham R Ball: Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach. Artificial Intelligence in Medicine 07/2008; 43(2). DOI:10.1016/j.artmed.2008.03.001 Impact factor: 1.355 SNIP: 1.869 Citations:49
  49. A.Mukherjee, M. Shehata, R. Sharma, E. Rakha, I. Ellis, G. Ball, B. M. Ball, S. Chan: Predictive markers of response to neoadjuvant chemotherapy in locally advanced breast cancer (LAPC). Journal of Clinical Oncology 05/2008; 26(15). Impact factor: 20.982 SNIP:4.228 Citations:0
  50. AR Green, J. M. Garibaldi, D Soria, F Ambrogi, G Ball, PJG Lisboa, TA Etchells, P Boracchi, E Biganzoli, R. D. Macmillan, R. W. Blamey, D. G. Powe, EA Rakha, I. O. Ellis: Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods. Breast Cancer Research 05/2008; 10. DOI:10.1186/bcr1953 Impact factor:5.211 SNIP:1.47 Citations: 5
  51. SA Laversin, AK Miles, GR Ball, AD Gritzapis, S Perez, C Baxevanis, G Li, RC Rees: Expression analysis of novel biomarkers for breast cancer. Breast Cancer Research 05/2008; 10. DOI:10.1186/bcr1949 Impact factor:5.211 SNIP:1.47 Citations: 0
  52. Graham R. Ball: Computational & Statistical Methodologies to Identify Biomarkers in Cancer. Current Cancer Therapy Reviews 05/2008; 4(2). DOI:10.2174/157339408784310043 Impact factor: 0.45 SNIP: 0.156 Citations:0
  53. Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball, Robert C. Rees: Emerging Breast Cancer Biomarkers. Current Cancer Therapy Reviews 05/2008; 4(2). DOI:10.2174/157339408784310179 Impact factor: 0.45 SNIP: 0.156 Citations: 0
  54. B. Hornmark-Stenstam, R. W. Blarney, G. R. Ball, A. Oates: ONCOPOOL – A European Dataset of 17,600 cases of breast cancer. EJC Supplements 04/2008; 6(7). DOI:10.1016/S1359-6349(08)70394-X Impact Factor: 6.163 SNIP: 2.010 Citations:0
  55. A.R.Green, J. M. Garibaldi, D. Soria, F. Ambrogi, D. G. Powe, G. Ball, P. J. G. Lisboa, P. Boracchi, E. Biganzoli, I. O. Ellis: Identification of key breast cancer phenotypes. EJC Supplements 04/2008; 6(7). DOI:10.1016/S1359-6349(08)70761-4 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  56. M. Sundquist, R. W. Blarney, G. R. Ball, M. Blichert-Toft, L. Cataliotti, I. O. Ellis, R. Jakesz, M. Kerin, I. Monypenny, A. Oates: The influence of Lympho Vascular Invasion (LVI) on local (LR) and regional recurrences (RR) and survival: an ONCOPOOL study. EJC Supplements 04/2008; 6(7). DOI:10.1016/S1359-6349(08)70799-7 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  57. Andrew R Green, Jonathan M Garibaldi, Daniele Soria, Federico Ambrogi, Desmond G Powe, Graham Ball, Paulo Lisboa, Patrizia Boracchi, Elia Biganzoli, Ian Ellis: Identification of Novel Clinical Phenotypes of Breast Cancer by Immunohistochemical Analysis. Modern Pathology 01/2008; 21. Impact factor: 5.485 SNIP:2.15 Citations: 0
  58. Balwir Matharoo-Ball, Graham Ball, Robert Rees: Clinical proteomics: Discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches—A prostate cancer perspective. Vaccine 10/2007; 25 Suppl 2. DOI:10.1016/j.vaccine.2007.06.040 Impact factor:3.413 SNIP:1.193 Citations: 35
  59. S. El-Sheikh, A.R. Green, E.A. Rakha, R.A. Ahmed, E. C. Pais, M. J. Grainge, G. R. Ball, J. F. Robertson, D. M. Heery, I. O. Ellis: O-43 Global histone modifications in breast cancer tissue correlate with tumor phenotype, prognostic factors and patient outcome. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71733-0 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  60. R. W. Blamey, M. J. Mitchell, G. R. Ball, A. Green, R. Rampaul, S. Pinder, A. Lee, R. D. Macmillan, I. O. Ellis: O-91 Prognostic estimation: re-analysis of data from cases diagnosed in 1990–99 by Cox proportional hazards method. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71781-0 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  61. R. S. Rampaul, M. J. Mitchell, S. E. Pinder, C. E. Paish, R. W. Blamey, D. Abd El-Rehim, G. Ball, J. F. Robertson, I. O. Ellis: O-89 The effect of HER2 overexpression on survival in early breast cancer. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71779-2 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  62. R. W. Blamey, I. O. Ellis, S. E. Pinder, A. H. S. Lee, R. D. Macmillan, D. A. L. Morgan, J. F. R. Robertson, M. J. Mitchell, G. R. Ball, J. L. Haybittle, C. W. Elston: O-88 Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990 to 1999. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71778-0 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  63. M. J. Mitchell, G. Wishart, R. W. Blamey, G. R. Ball, I. O. Ellis: D-1 Absolute Gain. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71804-9 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  64. B. Hornmark-Stenstam, R. W. Blamey, G. R. Ball, M. J. Mitchell, M. Blichert-Toft, L. Cataliotti, I. O. Ellis, A. Fourquet, K. Holli, R. Jakesz, M. Kerin, I. Monypenny: ONCOPOOL - A European Database in 16,893 cases of breast cancer: comparison with SEER. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71699-3 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  65. R. W. Blamey, S. E. Pinder, G. R. Ball, I. O. Ellis, C. W. Elston, M. J. Mitchell, J. L. Haybittle: O-61 Reading the prognosis of the individual with breast cancer. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71751-2 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  66. R. Murali-Ganesh, D. G. Powe, A. Pancholi, G. R. Ball, E. Rakha, I. O. Ellis: O-93 ALCAM is an independent predictor of survival in unselected breast cancer. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71783-4 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  67. A.R. Green, J. M. Garibaldi, D. Soria, F. Ambrogi, G. Ball, P. J. G. Lisboa, T. A. Etchells, P. Boracchi, E. Biganzoli, R. D. Macmillan, R. W. Blamey, I. O. Ellis: O-59 Identification of sub-classes of breast cancer through consensus derived from automated clustering methods. EJC Supplements 09/2007; 5(3). DOI:10.1016/S1359-6349(07)71749-4 Impact Factor: 6.163 SNIP: 2.010 Citations:0
  68. B Matharoo-Ball, C Hughes, L Lancashire, D Tooth, G Ball, C Creaser, M Elgasim, R Rees, R Layfield, W Atiomo: Characterization of Biomarkers in Polycystic Ovary Syndrome (PCOS) Using Multiple Distinct Proteomic Platforms. Journal of Proteome Research 09/2007; 6(8). DOI:10.1021/pr070124b Impact factor: 4.173 SNIP:1.103 Citations: 25
  69. R.W. Blamey, S.E. Pinder, G.R. Ball, I.O. Ellis, C.W. Elston, M.J. Mitchell, J.L. Haybittle: Reading the prognosis of the individual with breast cancer. European Journal of Cancer 08/2007; 43(10). DOI:10.1016/j.ejca.2007.01.003 Impact Factor: 6.163 SNIP: 2.010 Citations:43
  70. R.W. Blamey, I.O. Ellis, S.E. Pinder, A.H.S. Lee, R.D. Macmillan, D.A.L. Morgan, J.F.R. Robertson, M.J. Mitchell, G.R. Ball, J.L. Haybittle, C.W. Elston: Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. European Journal of Cancer 08/2007; 43(10). DOI:10.1016/j.ejca.2007.01.016 Impact Factor: 6.163 SNIP: 2.010 Citations:150
  71. Balwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, Selma Ugurel, Amanda K Miles, Daniel J Weston, Robert Rees, Dirk Schadendorf, Graham Ball, Colin S Creaser: Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach. Proteomics. Clinical applications 06/2007; 1(6). DOI:10.1002/prca.200700022 Impact Factor: 2.959 SNIP: 0.602 Citations:37
  72. Joshua Boateng, Lee Lancashire, Pamela Brown, Murrium Ahmad, Balwir-Matharoo Ball, Robert Davy, Shi Yu Yang, Jane Roberts, Phil Teale, Cristiana Velloso, Robert Rees, Graham Ball, Geoffrey Goldspink, Colin Creaser: The Use Of Proteomic And Bioinformatics Techniques For The Detection Of Protein Biomarkers Following Growth Hormone Administration. Internet Journal of Genomics and Proteomics 01/2007; 2(2). Impact factor:n/a SNIP:n/a Citations: 5
  73. Mike Whelan, Graham Ball, Chris Beattie, Angus Dalgleish: Biomarkers for development of cancer vaccines. Personalized Medicine 02/2006; 3(1). DOI:10.2217/17410541.3.1.79 Impact factor:1.000 SNIP:0.413 Citations: 3
  74. Carol Iversen, Lee Lancashire, Michael Waddington, Stephen Forsythe, Graham Ball: Identification of Enterobacter sakazakii from closely related species: The use of Artificial Neural Networks in the analysis of biochemical and 16S rDNA data. BMC Microbiology 02/2006; 6(1). DOI:10.1186/1471-2180-6-28 Impact factor: 2.581 SNIP:0.94 Citations: 33
  75. Oliver Schmid, Graham Ball, Lee Lancashire, Renata Culak, Haroun Shah: New Approaches to Identification of Bacterial Pathogens by Surface Enhanced Laser Desorption/Ionization Time of Flight Mass Spectrometry in Concert with Artificial Neural Networks, with Special Reference to Neisseria gonorrhoeae. Journal of Medical Microbiology 01/2006; 54(Pt 12). DOI:10.1099/jmm.0.46223-0 Impact factor:2.269 SNIP:0.969 Citations: 33
  76. Dalia M Abd El-Rehim, Graham Ball, Sarah E Pinder, Emad Rakha, Claire Paish, John F R Robertson, Douglas Macmillan, Roger W Blamey, Ian O Ellis: High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. International Journal of Cancer 09/2005; 116(3). DOI:10.1002/ijc.21004 Impact factor:5.531 SNIP:1.408 Citations:470
  77. Shahid Mian, Selma Ugurel, Erika Parkinson, Iris Schlenzka, Ian Dryden, Lee Lancashire, Graham Ball, Colin Creaser, Robert Rees, Dirk Schadendorf: Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology 09/2005; 23(22). DOI:10.1200/JCO.2005.03.164 Impact factor: 20.982 SNIP:4.228 Citations:111
  78. L Lancashire, O Schmid, H.N. Shah, G Ball: Classification of bacterial species from proteomic data using combinatorial approaches incorporating artificial neural networks, cluster analysis and principal components analysis. Bioinformatics 06/2005; 21(10). DOI:10.1093/bioinformatics/bti368 Impact factor:5.766 SNIP:1.729 Citations: 68
  79. Agnieska Michael, Graham Ball, Nadine Quatan, Fatima Wushishi, Nick Russell, Joe Whelan, Prabir Chakraborty, David Leader, Michael Whelan, Hardev Pandha: Michael, A, Ball, G, Quatan, N, Wushishi, F, Russell, N, Whelan, J et al.. Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables. Clin Cancer Res 11: 4469-4478. Clinical Cancer Research 06/2005; 11(12). DOI:10.1158/1078-0432.CCR-04-2337 Impact Factor: 8.738 SNIP: 1.933 Citations:125
  80. Lee J Lancashire, Shahid Mian, Ian O Ellis, Robert C Rees, Graham R Ball: Current Developments in the Analysis of Proteomic Data: Artificial Neural Network Data Mining Techniques for the Identification of Proteomic Biomarkers Related to Breast Cancer. Current Proteomics 04/2005; 200(1). DOI:10.2174/1570164053507808 Impact factor:0.49 SNIP:0.163 Citations: 20
  81. Shahid Mian, Graham Ball, Jo Hornbuckle, Finn Holding, James Carmichael, Ian Ellis, Selman Ali, Geng Li, Stephanie McArdle, Colin Creaser, Robert Rees: A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemo responsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions. Proteomics 09/2003; 3(9). DOI:10.1002/pmic.200300526 Impact factor:4.079 SNIP:0.915 Citations: 62
  82. L De Temmerman, G. Pihl Karlsson, A Donnelly, K Ojanperä, H.-J Jäger, J Finnan, G Ball: Factors influencing visible ozone injury on potato including the interaction with carbon dioxide. European Journal of Agronomy 11/2002; 17(4). DOI:10.1016/S1161-0301(02)00067-9 Impact factor:3.186 SNIP:1.924 Citations: 25
  83. Graham R. Ball, Shahid Mian, F. Holding, R. O. Allibone, J. Lowe, S. Ali, G. Li, S. McCardle, I. O. Ellis, Colin Creaser, Robert C. Rees: An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 03/2002; 18(3). Impact factor:5.766 SNIP:1.729 Citations: 263
  84. P. BUNGENER, G. R. BALLS, S. NUSSBAUM, M. GEISSMANN, A. GRUB, J. FUHRER: Leaf injury characteristics of grassland species in relation to soil moisture condition and vapour pressure deficit. New Phytologist 01/2002; 142(2). DOI:10.1046/j.1469-8137.1999.00390.x Impact factor:7.21 SNIP:1.86 Citations: 62
  85. G Mills, G Ball, F Hayes, J Fuhrer, L Skärby, B Gimeno, L De Temmerman, A Heagle: Development of a multi-factor model for predicting the effects of ambient ozone on the biomass of white clover. Environmental Pollution 10/2000; 109(3). DOI:10.1016/S0269-7491(00)00057-9 Impact factor:4.839 SNIP:1.892 Citations: 23
  86. G.R Ball, D Palmer-Brown, J Fuhrer, L Skärby, B.S Gimeno, G Mills: Identification of non-linear influences on the seasonal ozone dose–response of sensitive and resistant clover clones using artificial neural networks. Ecological Modelling 05/2000; 129(2-3). DOI:10.1016/S0304-3800(00)00234-9 Impact factor:2.275 SNIP:1.281 Citations: 23
  87. J Benton, J Fuhrer, B.S Gimeno, L Skärby, D Palmer-Brown, G Ball, C Roadknight, G Mills: An international cooperative program indicates the widespread occurrence of ozone injury on crops. Agriculture Ecosystems & Environment 03/2000; 78(1-78). DOI:10.1016/S0167-8809(99)00107-3 Impact factor:3.564 SNIP:1.674 Citations: 120
  88. G. R Ball, J Benton, D Palmer-Brown, J Fuhrer, Skärby LS, B. S Gimeno, G Mills: Identifying factors which modify the effects of ambient ozone on white clover (Trifolium repens) in Europe. Environmental Pollution 10/1998; 103(1). DOI:10.1016/S0269-7491(98)00147-X Impact factor:4.839 SNIP:1.892 Citations: 30
  89. Chris M. Roadknight, Graham R. Balls, Gina E. Mills, Dominic Palmer-Brown: Modeling complex environmental data. IEEE Transactions on Neural Networks 02/1997; 8(4). DOI:10.1109/72.595883 Impact factor:4.55 SNIP: n/a Citations: 86
  90. G. R. BALLS, D. PALMER-BROWN, G. E. SANDERS: Investigating microclimatic influences on ozone injury in clover (Trifolium subterraneum) using artificial neural networks. New Phytologist 02/1996; 132(2). DOI:10.1111/j.1469-8137.1996.tb01846.x Impact factor:7.21 SNIP:1.86 Citations: 54
  91. G. R. Balls, D. Palmer-Brown, AH Cobb, G. E. Sanders: Towards unravelling the complex interactions between microclimate, ozone dose, and ozone injury in clover. Water Air and Soil Pollution 12/1995; 85(3). DOI:10.1007/BF00477188 Impact factor:1.554 SNIP: 0.934 Citations: 17

See all of Graham Ball's publications...

Press expertise

  • Machine learning and Artificial Intelligence in Biosciences and Medicine
  • Biomarker discovery
  • Stratified medicine
  • Systems biology bioinformatics